Clover Enters News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Clover Enters into Exclusive Agreement to Commercialize Quadrivalent Seasonal Influenza Vaccine in Mainland China

GlobeNewswire

February 19, 2023



Clover to leverage its established and growing commercial infrastructure to exclusively distribute Adimmune’s AdimFlu-S (QIS), the only imported quadrivalent influenza vaccine approved in mainland China 1 Sasha D, Valinsky L, Hershkowitz Sikron. ....

Elaine Qiu , Albert Liao , Hershkowitz Sikron , Joshua Liang , Corporate Communications , Clover Biopharmaceuticals Ltd , Drug Administration , European Medicines Agency , Adimmune Corporation For Clover , Clover Enters , Exclusive Agreement , Adimmune Corporation , Chief Executive Officer , Executive Director , Chi Hsien Chan , China National Medical Products Administration ,